Betaine and nonalcoholic steatohepatitis: Back to the future?

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Nonalcoholic steatohepatitis (NASH) is an important indication for liver transplantation in many Western countries. Obesity and insulin resistance are the two most common risk factors for NASH, which can lead to recurrent NASH after liver transplantation. There is currently no approved therapy for NASH, and treatment is directed at risk factor modifcation and lifestyle changes. Betaine has been used for NASH, with mixed results, and may show promise in conjunction with other agents in clinical trials.

Original languageEnglish (US)
Pages (from-to)3663-3664
Number of pages2
JournalWorld Journal of Gastroenterology
Volume17
Issue number32
DOIs
StatePublished - Aug 28 2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Fingerprint Dive into the research topics of 'Betaine and nonalcoholic steatohepatitis: Back to the future?'. Together they form a unique fingerprint.

Cite this